BCL2 and cancer: It has been proposed that BAG3 is a co-chaperone of HSP70 induced by the HSF-1 transcription factor, and that it critically regulates Bcl-2 and Mcl-1 levels by inhibiting the proteasomal degradation of anti-apoptotic proteins, increasing the resistance of cancer cells to various therapies [311].